| Dr Terry D Ford, MD | |
|
639 Highway 528, Bay Springs, MS 39422-4823 | |
| (601) 764-6848 | |
| Not Available |
| Full Name | Dr Terry D Ford |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 36 Years |
| Location | 639 Highway 528, Bay Springs, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912922949 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 12405 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tyler Holmes Memorial Hospital Cah | Winona, MS | Hospital |
| South Baldwin Regional Medical Center | Foley, AL | Hospital |
| Choctaw General Hospital | Butler, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Correct Care, Inc. | 8628980992 | 68 |
| Ies Alabama Pllc | 5395105183 | 24 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Entity Name | Covington County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518260330 PECOS PAC ID: 4183517253 Enrollment ID: O20040203000816 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Entity Name | Magee Benevolent Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225157258 PECOS PAC ID: 3678466463 Enrollment ID: O20040205000400 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Entity Name | Forrest County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295837631 PECOS PAC ID: 1052397767 Enrollment ID: O20040624001351 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Entity Name | Kings Daughters Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043245368 PECOS PAC ID: 3072575539 Enrollment ID: O20041028000174 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Entity Name | Keystone Medical Services Of Ms Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174691059 PECOS PAC ID: 7618075177 Enrollment ID: O20070606000447 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Entity Name | Attala Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407103294 PECOS PAC ID: 5294984340 Enrollment ID: O20121004000363 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Entity Name | Correct Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20131122000662 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Entity Name | Carr, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548677610 PECOS PAC ID: 1850512153 Enrollment ID: O20160707000686 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terry D Ford, MD Po Box 329, Bay Springs, MS 39422-0329 Ph: (601) 764-6848 | Dr Terry D Ford, MD 639 Highway 528, Bay Springs, MS 39422-4823 Ph: (601) 764-6848 |
News Archive
In cancer patients nearing the end of life, certain subtypes of delirium—specifically, hypoactive and "mixed" delirium—are a strong indicator that death will come soon, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
In an article published today in the peer-reviewed, open-access SPIE publication Neurophotonics, "High density functional diffuse optical tomography based on frequency domain measurements improves image quality and spatial resolution," researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.
IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
› Verified 3 days ago